Mapping Out Pharma’s Regulatory Future in Europe

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology, Regulatory Sourcebook, September 2021, Volume 2021 eBook, Issue 3
Pages: 46–48

There are expectations that changes to pharma regulations in the EU, forming part of the regions broader strategy for the industry, will be positive and should offer flexibility for industry to advance through innovation.

In November 2020, the European Commission (EC) published its Pharmaceutical Strategy for Europe, which comprises four main objectives: affordable medicines access; support of the European Union’s pharma industry’s competitiveness, innovation, and sustainability; boosting crisis preparedness and response; and strengthening the EU’s global position in pharma. Additionally, as part of its broader strategy, the EC published its roadmap for revising pharmaceutical legislation in March 2021. Here, experts will discuss the strategy in greater detail and will also touch upon the potential for regulatory alignment between the European Union and United Kingdom post-Brexit.


Read in this article in Pharmaceutical Technology’s September 2021 Regulatory Sourcebook eBook.

Article Details

Pharmaceutical Technology
eBook: Regulatory Sourcebook
September 2021
Pages: 46–48


When referring to this article, please cite it as F. Thomas, “Mapping Out Pharma’s Future,” Pharmaceutical Technology’s Regulatory Sourcebook eBook (September 2021).